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Table 1. Independent determinants of homocysteine and transcobalamin in 55 hemodialysis patients
95% P value P value
Dependent Independent Correlation confidence univariate multiple
determinant determinant coefficient interval regression regressiona
Homocysteine
Creatinine 0.448 0.249, 0.685 0.0002 <0.0001
Folate −0.462 −0.652, −0.216 0.0005 0.0005
Cholesterol 0.314 0.018, 0.559 0.0377 0.1268
Triglycerides 0.279 −0.019, 0.532 0.0664 0.1417
Albumin 0.213 −0.076, 0.469 0.1471 0.9518
Vitamin B12 −0.167 −0.418, 0.234 0.2342
C-reactive prot −0.142 −0.415, 0.155 0.3496
Transcobalamin 0.103 −0.184, 0.373 0.4841
ALAT 0.132 −0.416, 0.175 0.5562
Transcobalamin
ALAT 0.636 0.417, 0.784 <0.0001 <0.0001
Creatinine 0.190 −0.099, 0.450 0.1179 0.0609
Cholesterol −0.225 −0.486, 0.073 0.1380 0.0655
Albumin −0.123 −0.391, 0.164 0.4013
Folate −0.117 −0.383, 0.167 0.4197
Homocysteine 0.103 −0.184, 0.373 0.4841
C-reactive prot −0.083 −0.367, 0.216 0.5920
Vitamin B12 −0.076 −0.344, 0.204 0.5978
Triglycerides −0.032 −0.322, 0.264 0.8375
aThe multiple regression analysis included only the parameters that presented a P value lower than 0.2 in univariate analysis.
or MTHFR polymorphisms, and found a weak effect of
TCN 776G × MTHFR 677T allele combination on ho-
mocysteine (carriers vs. noncarriers 40.5 ± 11.3 vs. 30.9 ±
10.7 lmol/L, P = 0.0158). The single determi-
nant of plasma apo-transcobalamin was alanine-
aminotransferase, while creatinine was under the limit
of significance (Table 1). The level was higher in ESRD,
compared to 109 matched controls (719 ± 354 vs. 464 ±
160 pmol/L, P < 0.0001). ESRD increased plasma
transcobalamin by an unknown mechanism, possibly re-
lated to glomerular filtration and tubular uptake. Un-
der these conditions, the influence of TCN 776C>G on
plasma transcobalamin may be limited, despite its effect
on TCN transcription and transcobalamin intracellular
concentration [3]. Therefore, in our opinion, the data of
the authors are less conflicting than suggested because the
weak influence of TCN 776C>G was initially reported in
a healthy population without low serum B12 [1], drug use
[1], and renal dysfunction [2].
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Microinflammation versus
inflammation in chronic renal
failure patients
To the Editor: In their study, Pupim et al [1] show that
patients with end-stage renal failure (ESRF) in the high-
est quartile of C-reactive protein (CRP) and interleukin-6
(IL-6) before hemodialysis (HD) initiation have a signif-
icant decrease in the serum level of both markers after
12 months of HD treatment. The baseline levels for IL-6
and CRP in these subgroups were about 58 pg/mL and
62 mg/L, respectively. As the authors note, no exclusion
criteria were used for enrollment in the study. These CRP
and IL-6 serum levels are probably indicative of an infec-
tion or other cause of “real inflammation” (trauma, ma-
lignancy, etc.). In the referred study microinflammation
investigation is warranted. It is low-grade inflammation
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that is correlated to atherosclerosis or other threatening
processes. Recently, a cut-off for CRP (10 mg/L) indica-
tive for inflammation versus microinflammation was es-
tablished for the general population [2]. We also found a
similar cut-off for CRP and IL-6 (9.5 mg or pg/L) indica-
tive for an inflammatory clinical event, in a group of HD
patients [3]. Possibly this cut-off is higher in other HD
patients, but, as the results in the majority of studies with
ESRF patients show, it seems improbable to be higher
than 15 mg/L for the CRP.
The study of Pupim et al is very interesting; it shows
convincingly, for the first time, that HD may not be a prin-
cipal cause of inflammation and oxidative stress in ESRF
patients. Although possibly the results are not essentially
influenced from the above-mentioned observation, accu-
rate assessment [4] and distinction between microinflam-
mation and inflammation is needed in all studies in this
research field.
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